Showing results (51-60 of 502) with videos related to
Sort By:
Pageof 51
Leukemia Research Reports|December 24, 2019
Inotuzumab ozogamicin as chemotherapy-sparing salvage in a 67-year-old man with primary refractory B-cell acute lymphoblastic leukemia with high-risk genomic featuresXiaochuan Yang, Filiz Sen, Mark B GeyerLeukemia Research Reports|December 24, 2019
Laryngeal mucous membrane plasmacytosis with 15 year follow-up: Case report and literature reviewVladislav V Makarenko, Alec E Vaezi, Doreen B Brettler, et al.Leukemia Research Reports|October 7, 2020
Primary adrenal extranodal NK/T-cell lymphoma: A case report and literature reviewSatoshi Ichikawa, Kei Saito, Noriko Fukuhara, et al.Leukemia Research Reports|May 5, 2016
The formation of an aberrant PAX5 transcript in a patient with mixed phenotype acute leukemia harboring der(9)t(7;9)(q11.2;p13)Jun Amaki, Hiromichi Matsushita, Yuka Kitamura, et al.Leukemia Research Reports|May 2, 2022
Observations on hematogones with light chain restrictionAngela D'Ardia, Valeria Ciliberti, Pio Zeppa, et al.Leukemia Research Reports|July 14, 2022
Erratum regarding missing informed consent statements in previously published articlesLeukemia Research Reports|October 27, 2015
Pharmacological targeting of PI3K isoforms as a therapeutic strategy in chronic lymphocytic leukaemiaMatthew D Blunt, Andrew J SteeleLeukemia Research Reports|July 29, 2014
An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromesStuart L Goldberg, Pierre Fenaux, Michael D Craig, et al.Leukemia Research Reports|December 28, 2013
New diagnosis of multiple myeloma in a patient with mantle cell lymphoma: Shared genetic factors or simple coincidence?Mutende J Sikuyayenga, Craig B Reeder, Joseph R MikhaelLeukemia Research Reports|December 28, 2013
Durable second complete remissions with oral melphalan in hypocellular Acute Myeloid Leukemia and Refractory Anemia with Excess Blast with normal karyotype relapsing after intensive chemotherapyAnnika M Whittle, Sylvia Feyler, David T BowenPageof 51